KRAS and small cell lung carcinoma: Using RAF-RBD coated beads, we pulled down active, GTP-bound KRAS from protein extracts of NCI-H196 and NCI-H82 cells, supporting that RAS/MAPK/ERK signaling is active in SCLC.